| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |